Continuous Therapy in Myeloma

Published on

Topics include: Treatments

Dr. Thomas Martin, associate director of the Myeloma Institute and director of the Unrelated Donor Transplantation Programs for adults at UCSF Medical Center, discusses which myeloma patients should stay on maintenance therapy—also known as continuous therapy—and the importance of ensuring that remission duration focuses on a desirable quality of life. Watch now.

 

View more programs featuring

Transcript

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

I try to tell my patients it should be like taking a vitamin.  It should not cause a lot of symptoms.  It should be that you take it once a day, and hopefully we'll protect that remission for a longer duration.  And we do that in patients after the transplant, and we also do it in patients that maybe are not a transplant candidate but have finished their what we call their debulking therapy, their initial therapy.  They've dropped their myeloma a substantial amount down, and now we'll put them on a suppressive dose of lenalidomide, or Revlimid. 

And that has been very effective in keeping patients in remission and again augmenting that remission duration where it's quality time. 

Please remember the opinions expressed on Patient Power are not necessarily the views of our sponsors, contributors, partners or Patient Power. Our discussions are not a substitute for seeking medical advice or care from your own doctor. That’s how you’ll get care that’s most appropriate for you.

Related Programs

How Doctors Decide Treatments for Newly Diagnosed Myeloma Patients

We're learning a lot about choosing the right treatment plan for each patient. Drs. Shaji Kumar and Noopur Raje talk about what information helps them decide the right plan for each patient.

Published:

Advertisement
Join Our Community Register for Events Read Our Latest Blog
Advertisement

Page last updated on April 7, 2015